Bio-Techne Corporation
TECH
$54.41
$1.492.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.23% | 4.72% | 4.46% | 2.41% | 1.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.23% | 4.72% | 4.46% | 2.41% | 1.97% |
| Cost of Revenue | 6.04% | 6.02% | 6.89% | 7.27% | 5.12% |
| Gross Profit | 4.82% | 4.08% | 3.27% | 0.11% | 0.47% |
| SG&A Expenses | 3.88% | 16.78% | 8.66% | 11.22% | 13.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.36% | 9.52% | 6.96% | 8.07% | 8.00% |
| Operating Income | 4.73% | -11.92% | -3.86% | -14.05% | -15.04% |
| Income Before Tax | -46.98% | -29.85% | -26.11% | -38.03% | -45.17% |
| Income Tax Expenses | 42.52% | 6.72% | 1.31% | -32.30% | -66.96% |
| Earnings from Continuing Operations | -56.34% | -35.14% | -29.45% | -38.91% | -41.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.34% | -35.14% | -29.45% | -38.91% | -41.07% |
| EBIT | 4.73% | -11.92% | -3.86% | -14.05% | -15.04% |
| EBITDA | 2.78% | -8.27% | -2.63% | -9.69% | -9.95% |
| EPS Basic | -56.71% | -35.34% | -29.62% | -39.02% | -41.27% |
| Normalized Basic EPS | 13.64% | -7.78% | -3.51% | -15.32% | -20.23% |
| EPS Diluted | -56.67% | -33.87% | -27.25% | -37.31% | -40.19% |
| Normalized Diluted EPS | 14.70% | -7.08% | -2.79% | -14.49% | -19.44% |
| Average Basic Shares Outstanding | -0.25% | 0.27% | 0.26% | 0.20% | 0.33% |
| Average Diluted Shares Outstanding | -1.04% | -0.48% | -0.41% | -0.76% | -0.67% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.29% | 0.55% | 0.42% | 0.64% | 0.70% |